Genmab A (GMAB) Finished Goods (2023 - 2025)

Genmab A (GMAB) has disclosed Finished Goods for 3 consecutive years, with $13.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Finished Goods rose 18.18% year-over-year to $13.0 million, compared with a TTM value of $13.0 million through Dec 2025, up 18.18%, and an annual FY2025 reading of $13.0 million, up 18.18% over the prior year.
  • Finished Goods was $13.0 million for Q4 2025 at Genmab A, up from $11.0 million in the prior quarter.
  • Across five years, Finished Goods topped out at $13.0 million in Q4 2025 and bottomed at $9.0 million in Q4 2023.
  • Average Finished Goods over 3 years is $11.0 million, with a median of $11.0 million recorded in 2024.
  • The sharpest move saw Finished Goods increased 22.22% in 2024, then increased 18.18% in 2025.
  • Year by year, Finished Goods stood at $9.0 million in 2023, then increased by 22.22% to $11.0 million in 2024, then rose by 18.18% to $13.0 million in 2025.
  • Business Quant data shows Finished Goods for GMAB at $13.0 million in Q4 2025, $11.0 million in Q4 2024, and $9.0 million in Q4 2023.